CareDx, Inc. has grown revenue 14% a year over three years and 13% a year over five. Revenue growth, 3-year annual rate: +14% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: +13%, growth has picked up over the last three years. Years of annual history on file: 14, FY2012 to FY2025, as filed.

CDNACareDx, Inc.

Healthcare

$63.68+336% 1Y

$63.68

$14.2852 weeks$69.81

Is it growing?

Excellent

Growing: revenue growing +34% year on year, earnings up +97% year on year, and operating margin widening (+7.2 points).

3 good

Revenue trend+34% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +13% a year.

Earnings trend+97% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+7.2 points operating

Trailing-twelve-month operating margin, 20.3% now against 13.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 78% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CDNA growing?

CareDx, Inc. has grown revenue 14% a year over three years and 13% a year over five.

+14%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +13%
Revenue growth, 5-year rate · +14% over three · growth has picked up over the last three years
Years of annual history on file: 14
Years of annual history on file · FY2012 to FY2025, as filed

Details›